CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionP/E ratio is 168.94×, higher than 95% of its Medical Instruments & Supplies peers (median 28.57×)
- FinancialsAltman Z-Score 5.8: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.27%Below 5Y avg (0.78%)
Annual Rate
CNY 0.07Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jul 31, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.79BCNY566.34M · vs all stocks (USD)
Trailing P/E
168.94xvs Medical Instruments & Supplies peers
Revenue (TTM)
573.29MCNY85.58M · vs all stocks (USD)
Profit Margin
3.96%vs Medical Instruments & Supplies peers
Beta
0.6290xvs all stocks
52-Week Change
52.54%vs all stocks
Market Capitalization
3.79BCNY566.34M · vs all stocks (USD)
Enterprise Value
3.38BCNY504.10M · vs all stocks (USD)
Trailing P/E
168.94xvs Medical Instruments & Supplies peers
Forward P/E
44.31xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.62xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.07xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.89xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
23.20xvs Medical Instruments & Supplies peers
Gross Margin
42.61%vs Medical Instruments & Supplies peers
Profit Margin
3.96%vs Medical Instruments & Supplies peers
Operating Margin
22.33%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.15%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.93%vs Medical Instruments & Supplies peers
Revenue (TTM)
573.29MCNY85.58M · vs all stocks (USD)
Revenue per Share (TTM)
4.12CNYUpdated Sep 22, 2026Quarterly Revenue Growth
17.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
228.08MCNY34.05M · vs all stocks (USD)
EBITDA (TTM)
106.54MCNY15.90M · vs all stocks (USD)
Net Income (TTM)
22.71MCNY3.39M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-16.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
142.69MCNY21.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
8.03MCNY1.20M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0740CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.27%vs all stocks
5-Year Average Dividend Yield
0.78%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
8.86MCNYFY2025 · Dec 31, 2025Revenue
563.98MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
330.53MCNYFY2025 · Dec 31, 2025Gross Profit
233.45MCNYFY2025 · Dec 31, 2025Operating Income
108.93MCNY16.26M · vs all stocks (USD)
Pre-tax Income
60.93MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.84MCNYFY2025 · Dec 31, 2025Net Income
49.09MCNYFY2025 · Dec 31, 2025EBIT
89.19MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
169.45MCNYFY2025 · Dec 31, 2025Research & Development
29.12MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
24.34MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
28.25MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
137.82MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
137.82MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
49.09MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-858.30KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
126.53MCNYFY2025 · Dec 31, 2025Free Cash Flow
2.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
243.95MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
49.09MCNYFY2025 · Dec 31, 2025Other Non-cash Items
30.41MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
57.71MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-10.68MCNYFY2025 · Dec 31, 2025Capital Expenditures
-123.74MCNYFY2025 · Dec 31, 2025Purchase of Investments
-567.29MCNYFY2025 · Dec 31, 2025Sale of Investments
590.24MCNYFY2025 · Dec 31, 2025Other Investing Activity
52.21MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-48.58MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-14.45MCNYFY2025 · Dec 31, 2025Other Financing Charges
-872.08KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.32MCNYFY2025 · Dec 31, 2025Shares Outstanding
140.36MSharesUpdated Sep 22, 2026Float Shares
69.13MSharesUpdated Sep 22, 2026% Held by Insiders
48.58%vs all stocks
% Held by Institutions
4.75%vs all stocks
Total Cash (MRQ)
455.90MCNY68.05M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.36CNYUpdated Sep 22, 2026Total Debt (MRQ)
395.33MCNY59.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3272xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
7.75xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
8.80CNYUpdated Sep 22, 2026Total Assets
1.74BCNY259.93M · vs all stocks (USD)
Total Current Assets
809.53MCNYFY2025 · Dec 31, 2025Total Liabilities
516.17MCNYFY2025 · Dec 31, 2025Total Non-current Assets
931.79MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
408.59MCNYFY2025 · Dec 31, 2025Total Current Liabilities
107.58MCNYFY2025 · Dec 31, 2025Cash
347.53MCNYFY2025 · Dec 31, 2025Cash Equivalents
217.36KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
347.75MCNYFY2025 · Dec 31, 2025Other Short-term Investments
50.24MCNYFY2025 · Dec 31, 2025Accounts Receivable
136.18MCNYFY2025 · Dec 31, 2025Inventory
133.52MCNYFY2025 · Dec 31, 2025Accounts Payable
39.67MCNYFY2025 · Dec 31, 2025Short-term Debt
4.49MCNYFY2025 · Dec 31, 2025Other Current Liabilities
5.64MCNYFY2025 · Dec 31, 2025Long-term Debt
382.90MCNYFY2025 · Dec 31, 2025Common Stock (Book)
140.36MCNYFY2025 · Dec 31, 2025Retained Earnings
511.32MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.23BCNY182.88M · vs all stocks (USD)
Treasury Stock
30.00MCNYFY2025 · Dec 31, 202552-Week Low
11.26CNYUpdated Sep 22, 202652-Week High
27.40CNYUpdated Sep 22, 202652-Week Change
52.54%vs all stocks
Beta
0.6290xvs all stocks
50-Day MA
16.75CNYUpdated Sep 22, 2026200-Day MA
16.49CNYUpdated Sep 22, 2026Avg 10-Day Volume
7.82MSharesUpdated Sep 22, 2026Avg 30-Day Volume
8.03MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1600CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 168.94×, higher than 95% of its Medical Instruments & Supplies peers (median 28.57×)Significant
P/E ratio: 168.938Industry median: 28.57Industry P95: 136.055Peers compared: 59.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: 0.04
Financial Health
Altman Z-Score 5.8: safe zoneNotable
Altman Z-Score: 5.80
High earnings qualityNotable
Earnings Quality Score: 0.60
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Taiwan Sakura Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Changshu Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Chinastars New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Oil HBP Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Xiantong Rubber Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Saimo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Suzhou Alton Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Alpha Networks Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eastone Century Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yongji Printing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule